Editorial: Immune-related adverse events for patients with lung cancer-volume II

• Yusha Wang,
• Xia Wang,
• Cheng Zhan,
• Benjamin Frey,
• Udo S. Gaipl,
• Hubing Shi,
• Xuelei Ma

Affiliations

Yusha Wang

Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China

Xia Wang

Department of Biotherapy Research, West China Hospital, Sichuan University, Chengdu, Sichuan, China

Cheng Zhan

Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China

Benjamin Frey

Department of Radiation Oncology, Universitätsklinikum Erlangen, Erlangen, Germany

Udo S. Gaipl

Department of Radiation Oncology, Universitätsklinikum Erlangen, Erlangen, Germany

Hubing Shi

Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China

Xuelei Ma

Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China